Creating Transparency and Fairness in Automated Decision Systems for Administrative Agencies
Summary
Artificial intelligence is increasingly being used to make decisions about human welfare. Automated decision systems (ADS) administer U.S. social benefits programs—such as unemployment and disability benefits—across local, state, and Federal governments. While ADS have the potential to enable large gains in efficiency, they also run a high risk of reinforcing the class- and race-based inequities of the status quo. Additionally, the use of these systems is not transparent, often leaving individuals with no meaningful recourse after a decision has been made. Individuals may not even know that ADS played a role in the decision-making process.
The Federal Government should take immediate action to promote the transparency and accountability of automated decision systems. Agencies must build internal technical capacity as well as data cultures centered around transparency, accountability, and fairness. The White House should require that agencies using ADS undertake a notice-and-comment process to disclose information about these systems to the public. Finally, in the long-term, Congress must pass comprehensive legislation to implement a single, national standard regulating the use of ADS across sectors and use cases.
To better understand what might drive the way we live, learn, and work in 2050, we’re asking the community to share their expertise and thoughts about how key factors like research and development infrastructure and automation will shape the trajectory of the ecosystem.
Recognizing the power of the national transportation infrastructure expert community and its distributed expertise, ARPA-I took a different route that would instead bring the full collective brainpower to bear around appropriately ambitious ideas.
NIH needs to seriously invest in both the infrastructure and funding to undertake rigorous nutrition clinical trials, so that we can rapidly improve food and make progress on obesity.
Modernizing ClinicalTrials.gov will empower patients, oncologists, and others to better understand what trials are available, where they are available, and their up-to-date eligibility criteria, using standardized search categories to make them more easily discoverable.